Understanding the Diagnosis and Genetics of Lamellar Ichthyosis
At a Glance
Lamellar ichthyosis is a rare inherited skin-barrier disorder often recognized after a newborn’s collodion membrane sheds. Clinical examination and genetic testing help confirm the diagnosis, identify the gene involved, and explain the 25% risk in each pregnancy when both parents are carriers.
The diagnosis of Lamellar Ichthyosis (LI) often begins in the delivery room with a striking and unexpected appearance. Understanding why this happens requires looking deep into the genetic “blueprint” of the skin. LI is a specific form of Autosomal Recessive Congenital Ichthyosis (ARCI), a group of rare genetic skin disorders where the skin’s natural barrier does not form correctly [1].
Because LI is exceptionally rare—affecting approximately 1 in 250,000 to 300,000 live births—it is common for local doctors or pediatricians to have never seen a case in person [2][3]. This rarity often makes the diagnostic journey feel isolating, but the underlying biological cause is well-documented in medical literature.
The ‘Collodion Baby’ Presentation
Most children with LI are born as collodion babies. This term describes a newborn covered in a tight, shiny, translucent membrane that resembles plastic wrap or dried collodion [4]. This membrane is not the disease itself, but rather a temporary “phenotype” (outward appearance) that occurs in several types of ARCI [5].
The membrane typically behaves in a predictable way:
- Tightness: It can pull on the delicate skin around the eyes and mouth, causing them to turn slightly outward (ectropion of the eyes and eclabium of the lips) [6].
- Shedding: Within the first 2 to 4 weeks of life, the membrane dries out and begins to peel or shed [4].
- Transition: As the membrane falls away, the lifelong skin appearance of LI emerges. While some forms of the condition (like “self-healing collodion baby”) see the skin clear up, children with LI will begin to develop generalized, thick, dark-brown, plate-like scales [1][7].
The Genetics of the Skin Barrier
The skin’s outermost layer acts like a brick wall. In a healthy person, “bricks” (skin cells) are held together by “mortar” (a specialized lipid envelope made of fats). In LI, a genetic mutation provides the body with the wrong instructions, and this “mortar” is never properly mixed or applied [8].
The most common gene involved is TGM1, which provides instructions for an enzyme called transglutaminase 1. This enzyme is responsible for “cross-linking” fats to the skin cells to create a waterproof seal [8][9]. Without this seal, the skin cannot hold onto moisture and becomes thick and scaly as it tries to protect itself.
While TGM1 is the most frequent cause, mutations in several other genes can lead to LI or similar forms of ARCI:
- ABCA12: Responsible for transporting fats into the skin layers [10].
- ALOX12B and ALOXE3: Help process skin fats [11].
- CYP4F22, PNPLA1, and CERS3: Work together to create acylceramides, a critical type of fat for the skin barrier [12][13][14].
- NIPAL4: Involved in how skin cells organize their fat layers [15].
- SDR9C7 and SULT2B1: Help finish the final steps of building the waterproof barrier [16][17].
The Role of Genetic Testing
While doctors make a clinical diagnosis by examining the skin, genetic testing (often using a multigene panel) is a highly recommended tool during specialist evaluations for confirming a diagnosis of LI [18]. Because many forms of ARCI look similar at birth, looking at the DNA can provide additional clarity.
Genetic testing offers several benefits, though it is important to understand its limitations:
- Guiding the Diagnosis: It helps distinguish LI from other conditions like Congenital Ichthyosiform Erythroderma (CIE) [7]. However, testing panels vary in coverage, and finding a “variant of uncertain significance” or having a negative result does not rule out the clinical diagnosis of LI or ARCI.
- Understanding Patterns: While not a perfect crystal ball, knowing the specific gene can sometimes help doctors recognize common patterns—though it is important to note that a child’s specific genotype cannot perfectly predict their individual severity or risk for issues like overheating [6][19].
- Family Planning: Since LI is autosomal recessive, it means both parents must carry a disease-causing variant in the same gene. If they do, each future child has a 25% chance of being affected [20]. Genetic testing allows for accurate counseling for future pregnancies or for other family members [21].
In specialist centers, genetic testing provides vital information for many families, though clinical evaluation remains central to the care plan [22].
Beyond the Scales: Associated Features
As the diagnosis is confirmed, your medical team will also look for common physical features associated with LI. These can reflect the underlying disorder and vary by genotype, rather than just being caused by tight skin:
- Ectropion: Persistent outward turning of the eyelids, seen in many LI cases [7].
- Palmoplantar Hyperkeratosis: Excessive thickening of the skin on the palms of the hands and soles of the feet [23].
- Alopecia: Thinning hair or scarring on the scalp caused by thick scaling [7].
- Sweating Issues: Because the thick scales can block sweat glands, children with LI are often at risk of overheating due to anhidrosis (absent sweating) or hypohidrosis (reduced sweating) [6].
Knowing these genetic and physical markers helps your care team move from the initial shock of the birth to a concrete, evidence-based management plan.
Common questions in this guide
What is a collodion baby, and does it mean my child has lamellar ichthyosis?
How is lamellar ichthyosis diagnosed?
What gene is most often linked to lamellar ichthyosis?
What does autosomal recessive inheritance mean for future children?
What features besides scaling can occur with lamellar ichthyosis?
Can a genetic result predict how severe my child’s lamellar ichthyosis will be?
Get notified when new evidence is published on Lamellar ichthyosis.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (23)
- 1
Two Cases of Autosomal Recessive Congenital Ichthyosis due to CYP4F22 Mutations: Expanding the Genotype of Self-Healing Collodion Baby.
Noguera-Morel L, Feito-Rodríguez M, Maldonado-Cid P, et al.
Pediatric dermatology 2016; (33(2)):e48-51 doi:10.1111/pde.12740.
PMID: 26646773 - 2
Case Report: Whole exome sequencing helps in accurate molecular diagnosis in siblings with a rare co-occurrence of paternally inherited 22q12 duplication and autosomal recessive non-syndromic ichthyosis.
Gupta A, Sharma Y, Deo K, et al.
F1000Research 2015; (4()):446 doi:10.12688/f1000research.6779.1.
PMID: 26594337 - 3
Congenital ichthyosis presentation and outcome - A case series.
Ansari QA, Singh VA, Randad KG, Bansal P
Journal of family medicine and primary care 2023; (12(11)):2990-2993 doi:10.4103/jfmpc.jfmpc_1080_23.
PMID: 38186783 - 4
Autosomal Recessive Congenital Ichthyosis Due to Heterozygote Variants in the ALOX12B gene Presenting as Mild Nonbullous Congenital Ichthyosiform Erythroderma.
Hižar Gašpar I, Rešić A, Pustišek N, Odak L
Acta dermatovenerologica Croatica : ADC 2024; (32(3)):159-162.
PMID: 40654215 - 5
Collodion Baby with TGM1 gene mutation.
Sharma D, Gupta B, Shastri S, et al.
International medical case reports journal 2015; (8()):205-8 doi:10.2147/IMCRJ.S91517.
PMID: 26451124 - 6
Prenatal diagnosis of harlequin ichthyosis by ultrasonography: a case report.
Zhou XJ, Lin YJ, Chen XW, et al.
Annals of translational medicine 2021; (9(2)):183 doi:10.21037/atm-20-8223.
PMID: 33569485 - 7
Spectrum of Autosomal Recessive Congenital Ichthyosis in Scandinavia: Clinical Characteristics and Novel and Recurrent Mutations in 132 Patients.
Pigg MH, Bygum A, Gånemo A, et al.
Acta dermato-venereologica 2016; (96(7)):932-937 doi:10.2340/00015555-2418.
PMID: 27025581 - 8
Patients with congenital ichthyosis and TGM1 mutations overexpress other ARCI genes in the skin: Part of a barrier repair response?
Zhang H, Ericsson M, Weström S, et al.
Experimental dermatology 2019; (28(10)):1164-1171 doi:10.1111/exd.13813.
PMID: 30372788 - 9
A cellular disease model toward gene therapy of TGM1-dependent lamellar ichthyosis.
Sercia L, Romano O, Marini G, et al.
Molecular therapy. Methods & clinical development 2024; (32(3)):101311 doi:10.1016/j.omtm.2024.101311.
PMID: 39234443 - 10
Epidemiology, medical genetics, diagnosis and treatment of harlequin ichthyosis in Japan.
Shibata A, Akiyama M
Pediatrics international : official journal of the Japan Pediatric Society 2015; (57(4)):516-22 doi:10.1111/ped.12638.
PMID: 25857373 - 11
Meta-Analysis of Mutations in ALOX12B or ALOXE3 Identified in a Large Cohort of 224 Patients.
Hotz A, Kopp J, Bourrat E, et al.
Genes 2021; (12(1)) doi:10.3390/genes12010080.
PMID: 33435499 - 12
Essential role of the cytochrome P450 CYP4F22 in the production of acylceramide, the key lipid for skin permeability barrier formation.
Ohno Y, Nakamichi S, Ohkuni A, et al.
Proceedings of the National Academy of Sciences of the United States of America 2015; (112(25)):7707-12 doi:10.1073/pnas.1503491112.
PMID: 26056268 - 13
PNPLA1 has a crucial role in skin barrier function by directing acylceramide biosynthesis.
Hirabayashi T, Anjo T, Kaneko A, et al.
Nature communications 2017; (8()):14609 doi:10.1038/ncomms14609.
PMID: 28248300 - 14
Comprehensive stratum corneum ceramide profiling reveals reduced acylceramides in ichthyosis patient with CERS3 mutations.
Yamamoto M, Sassa T, Kyono Y, et al.
The Journal of dermatology 2021; (48(4)):447-456 doi:10.1111/1346-8138.15725.
PMID: 33492757 - 15
Decreased Skin Barrier Lipid Acylceramide and Differentiation-Dependent Gene Expression in Ichthyosis Gene Nipal4-Knockout Mice.
Honda Y, Kitamura T, Naganuma T, et al.
The Journal of investigative dermatology 2018; (138(4)):741-749 doi:10.1016/j.jid.2017.11.008.
PMID: 29174370 - 16
Knockdown of SDR9C7 Impairs Epidermal Barrier Function.
Youssefian L, Niaziorimi F, Saeidian AH, et al.
The Journal of investigative dermatology 2021; (141(7)):1754-1764.e1 doi:10.1016/j.jid.2020.11.030.
PMID: 33422619 - 17
Mutations in SULT2B1 Cause Autosomal-Recessive Congenital Ichthyosis in Humans.
Heinz L, Kim GJ, Marrakchi S, et al.
American journal of human genetics 2017; (100(6)):926-939 doi:10.1016/j.ajhg.2017.05.007.
PMID: 28575648 - 18
Whole-exome sequencing for diagnosis of hereditary ichthyosis.
Sitek JC, Kulseth MA, Rypdal KB, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV 2018; (32(6)):1022-1027 doi:10.1111/jdv.14870.
PMID: 29444371 - 19
Cross-Sectional Study on Autosomal Recessive Congenital Ichthyoses: Association of Genotype with Disease Severity, Phenotypic, and Ultrastructural Features in 74 Italian Patients.
Diociaiuti A, Corbeddu M, Rossi S, et al.
Dermatology (Basel, Switzerland) 2024; (240(3)):397-413 doi:10.1159/000536366.
PMID: 38588653 - 20
Compound heterozygous ABCA12 variants identified in a Chinese patient with congenital ichthyosiform erythroderma: Advancing genotype-phenotype correlations and literature review.
Liu JW, Guo K, Zhang R, et al.
Molecular genetics & genomic medicine 2024; (12(5)):e2431 doi:10.1002/mgg3.2431.
PMID: 38702946 - 21
Novel compound heterozygous variants in TGM1 with the lethal neonatal collodion baby and autosomal recessive congenital ichthyosis.
Pan Y, Xu H, Zeng M, et al.
Archives of dermatological research 2025; (317(1)):611 doi:10.1007/s00403-025-03796-w.
PMID: 40119962 - 22
Spectrum of ichthyoses in an Austrian ichthyosis cohort from 2004 to 2017.
Seidl-Philipp M, Schatz UA, Gasslitter I, et al.
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 2020; (18(1)):17-25 doi:10.1111/ddg.13968.
PMID: 31642606 - 23
Corneal ulcer secondary to ectropion in lamellar Ichthyosis: A rare congenital disorder.
Bhedasgaonkar SS, Nadkarni SU
Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society 2020; (34(1)):59-61 doi:10.4103/1319-4534.301289.
PMID: 33542991
This page is for informational purposes only and does not constitute medical advice. A dermatologist, geneticist, or genetic counselor can interpret your child’s examination and genetic test results.